05 Mar 2026 23:58 CET

Issuer

Elliptic Laboratories ASA

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR
INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY
OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE
SECURITIES DESCRIBED HEREIN.

Oslo, Norway --- Reference is made to the stock exchange announcement
published earlier today on 5 March 2026 by Elliptic Laboratories ASA (OSE:
ELABS) (the "Company") regarding a contemplated private placement (the
"Private Placement") of new shares in the Company (the "Offer Shares").

The Private Placement has been successfully placed, raising gross proceeds to
the Company of approximately NOK 60 million, through the allocation of
10,527,500 Offer Shares in Tranche 1 and conditional allocation of 10,522,500
Offer Shares in Tranche 2, each at an offer price of NOK 2.85 per Offer Share
(the "Offer Price"). The Private Placement attracted strong interest from both
new and existing investors and was substantially oversubscribed.

The net proceeds to the Company from the Private Placement will be used to
strengthen the balance sheet and fund organic growth initiatives, including
accelerating the commercialization of its embedded edge AI platform, expanding
its technology into new channels such as smart glasses and connected media
devices, and supporting further value expansion within its existing laptop and
smartphone portfolio.

In accordance with their pre-commitments the following primary insiders and
closely associated companies were allocated a total of 1,999,996 Offer Shares
in the Private Placement for a total amount of approx. NOK 5.7 million, to be
settled in full under Tranche 2:

* Alden AS, a company closely associated to Edvin Austbø (Board member), has
been allocated 1,473,684 Offer Shares equal to approx. NOK 4.2 million;
* Sven Tore Larsen (Chairperson of the Board) has been allocated 350,877 Offer
Shares equal to approx. NOK 1 million;
* Svein-Egil Nielsen (Board member) has been allocated 35,087 Offer Shares
equal to approx. NOK 100,000;
* Ingrid Elvira Leisner (Board member) has been allocated 35,087 Offer Shares
equal to approx. NOK 100,000;
* Berit Svendsen (Board member) has been allocated 35,087 Offer Shares equal
to approx. NOK 100,000;
* Ts Vekst AS, company closely associated to Ola Tviberg Sandstad (CEO), has
been allocated 35,087 Offer Shares equal to approx. NOK 100,000; and
* Mathias Norderud (CFO) has been allocated 35,087 Offer Shares equal to
approx. NOK 100,000.

Primary insider notifications regarding the Offer Shares will be provided
separately.

Settlement and timeline:
The Private Placement consists of two tranches, of which 10,527,500 Offer
Shares have been resolved to be issued in the first tranche ("Tranche 1") by
the Company's board of directors (the "Board") pursuant to an authorisation
granted by the Company's annual general meeting held on 21 May 2025 (the
"Board Authorisation"). The second tranche ("Tranche 2") consists of
10,522,500 Offer Shares and is conditional inter alia on approval by an
extraordinary general meeting (the "EGM") expected to be held on or about 27
March 2026, which will be summoned separately.

Settlement of Offer Shares in Tranche 1 is expected to take place on or about
11 March 2026, and settlement of Offer Shares in Tranche 2 is expected to take
place on or about 1 April 2026, subject to satisfaction of the conditions for
completion, as set out below.

The Offer Shares allocated in Tranche 1 will be tradeable on Euronext Oslo
Børs after the share capital increase pertaining to the issue of the Offer
Shares in Tranche 1 is registered with the Norwegian Register of Business
Enterprises ("NRBE"), expected on or about 10 March 2026. The Offer Shares in
Tranche 1 are expected to be pre-paid by the Manager pursuant to a pre-payment
agreement (the "Pre-Payment Agreement") between the Company and the Manager,
in order to facilitate prompt registration of the share capital increase
pertaining to the issue of the Offer Shares in Tranche 1 with the NRBE and DVP
settlement.

The Offer Shares allocated in Tranche 2 will be tradeable on Euronext Oslo
Børs following the registration of the share capital increase pertaining to
the Offer Shares in Tranche 2 in the NRBE expected to be on or about 31 March
2026. The Offer Shares in Tranche 2 are also expected to be pre-paid by the
Manager pursuant to the Pre-Payment Agreement and subject to the conditions
for completion of Tranche 2 having been met, including Tranche 2 having been
approved by the EGM. The Company will announce when the capital increase
pertaining to Tranche 1 and the capital increase pertaining to Tranche 2 has
been registered with the NRBE.

Notification of allocation of the Offer Shares (which is conditional with
respect to Tranche 2) and payment instructions are expected to be issued to
the applicants on or about 6 March 2026 before 09:00 CET through a
notification to be issued by the Manager.

Following completion of the share capital increase pertaining to Tranche 1,
the Company will have a share capital of NOK 1,158,142.65 divided into
115,814,265 shares, each with a nominal value of NOK 0.01. Furthermore,
following registration of the share capital increase in Tranche 2 with the
NRBE (subject e.g. to approval by the EGM), the Company will have a share
capital of NOK 1,263,367.65 divided into 126,336,765 shares, each with a
nominal value of NOK 0.01.

Conditions for completion:
Completion of Tranche 1 remains subject to (i) the Pre-Payment Agreement being
in full force and effect, (ii) the share capital increase pertaining to the
issuance of the Offer Shares in Tranche 1 being validly registered with the
NRBE, and (iii) the Offer Shares in Tranche 1 being validly issued and
registered in the Norwegian Central Securities Depository ( "VPS").

The completion of Tranche 2 is subject to (i) the completion of the conditions
relating to Tranche 1, (ii) the approval by the EGM of the issuance of the
Offer Shares under Tranche 2, (iii) the Pre-Payment Agreement being in full
force and effect, (iv) the share capital increase pertaining to the issuance
of the Offer Shares in Tranche 2 being validly registered with the NRBE, and
(v) the Offer Shares in Tranche 2 being validly issued and registered in VPS.

Completion of Tranche 1 is not conditional upon completion of Tranche 2. The
settlement of Offer Shares under Tranche 1 will remain final and binding and
cannot be revoked, cancelled or terminated by the respective applicants if
Tranche 2 is not completed.

The Company also reserves the right in its sole discretion to cancel Tranche 2
if the conditions for completion are not fulfilled. If Tranche 2 is not
completed (e.g. due to non-approval by the EGM), applicants will not be
delivered Offer Shares in Tranche 2, and the Company will only receive the
gross proceeds for the issue of the Offer Shares issued in Tranche 1. Neither
the Company, nor the Manager, or any of their respective directors, officers,
employees, representatives or advisors, will be liable for any losses if the
Private Placement as a whole (including Tranche 1), or just Tranche 2, is
cancelled, irrespective of the reason for such cancellation.

Lock-up undertakings:
In connection with the Private Placement, the Company as well as members of
the Company's management and Board have agreed to a 6-month lock-up with the
Manager, subject to certain customary exceptions.

Voting undertaking:
Existing shareholders in the Company which are allocated Offer Shares in the
Private Placement will irrevocably undertake to vote in favour of, or give a
voting proxy to be used in favour of, all of the Board's proposed resolutions
relating to the Private Placement and the Subsequent Offering (as defined
below) at the EGM. Such undertaking applies to all shares in the Company held
or controlled (directly or indirectly) by such existing shareholders as of the
record date for the EGM.

Equal treatment considerations and Subsequent Offering:
The Private Placement represents a deviation from the shareholders'
pre-emptive right to subscribe for the Offer Shares. The Board has carefully
considered the contemplated Private Placement in light of the equal treatment
obligations under the Norwegian Public Limited Companies Act and Norwegian
Securities Trading Act. The Board holds the view that it is in the common
interest of the Company and its shareholders to raise equity through the
Private Placement, in view of the current market conditions and the funding
alternatives currently available to the Company. The Private Placement has
reduced execution and completion risk, as it has enabled the Company to raise
capital in an efficient and timely manner, at a lower cost and with a
significantly reduced completion risk compared to e.g. a rights issue. On this
basis, the Board has considered the proposed transaction structure and the
Private Placement to be in the common interest of the Company and its
shareholders.

The Board will propose that the EGM resolves to provide the Board with an
authorisation to conduct a subsequent offering of 10,500,000 new shares in the
Company at a subscription price per share corresponding to the Offer Price in
the Private Placement (the "Subsequent Offering"). The total maximum
subscription amount of the Subsequent Offering is expected to be approx. NOK
30 million. The Subsequent Offering will, if made, be subject to among other
things (i) completion of the Private Placement, (ii) relevant corporate
resolutions, including approval by the Board, and the EGM approving a board
authorisation to issue shares in the Subsequent Offering, (iii) the
preparation, approval and publication of a prospectus for the Subsequent
Offering, and (iv) the prevailing market price of the Company's shares
following the Private Placement. The Subsequent Offering would be directed
towards existing shareholders in the Company as of 5 March 2026 (as registered
in VPS two trading days thereafter) who (i) were not included in the
pre-sounding phase of the Private Placement, (ii) were not allocated Offer
Shares in the Private Placement, and (iii) are not resident in a jurisdiction
where such offering would be unlawful or would (in jurisdictions other than
Norway) require any prospectus, filing, registration or similar action. The
Company will issue a separate stock exchange notice with the key information
relating to the Subsequent Offering. The Company reserves the right in its
sole discretion to not conduct or to cancel the Subsequent Offering and will,
if and when finally resolved, issue a separate stock exchange notice with
further details on the Subsequent Offering.

Advisors:
Pareto Securities AS is acting as sole manager and bookrunner in connection
with the Private Placement. Advokatfirmaet Wiersholm AS is acting as the
Company's legal advisor.

For more information, please contact:
CEO Ola Tviberg Sandstad, ola.sandstad@ellipticlabs.com
CFO Mathias Norderud, mathias.norderud@ellipticlabs.com

About Elliptic Labs
Elliptic Labs is a global Edge AI company delivering trusted, low-power
on-device sensing at scale. Our AI Virtual Smart Sensor PlatformTM enables
intelligent, always-on contextual awareness directly on devices --- without
the need for additional hardware or continuous cloud processing.

Deployed in over 500 million devices worldwide, our platform powers
software-defined sensing across a broad range of consumer and enterprise
products. By executing compact neural networks directly on-device, our
technology delivers adaptive, real-time sensing that preserves user privacy
while minimizing power consumption.

For more than a decade, Elliptic Labs has specialized in efficient neural
network execution using proprietary runtimes and custom-built sensing models
optimized for real-world environments. Built on balanced, self-collected
datasets and engineered to operate across diverse hardware architectures, our
AI Virtual Smart Sensors enable seamless integration across product
generations and device categories.

Our solutions enhance security, personalization, productivity, and user
experience --- forming a scalable foundation for the next generation of
AI-enabled devices.
Headquartered in Norway, with a presence in the USA, China, South Korea,
Taiwan, and Japan, Elliptic Labs is listed on the Oslo Stock Exchange. All
technology and intellectual property are developed in Norway and are solely
owned by the company, ensuring independence and long-term innovation.

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act.

Important information:
This announcement is not and does not form a part of any offer to sell, or a
solicitation of an offer to purchase, any securities of the Company. Copies of
this announcement are not being made and may not be distributed or sent into
any jurisdiction in which such distribution would be unlawful or would require
registration or other measures.

The securities referred to in this announcement have not been and will not be
registered under the U.S. Securities Act of 1933, as amended (the "Securities
Act"), and accordingly may not be offered or sold in the United States absent
registration or an applicable exemption from the registration requirements of
the Securities Act and in accordance with applicable U.S. state securities
laws. The Company does not intend to register any part of the offering in the
United States or to conduct a public offering of securities in the United
States. Any sale in the United States of the securities mentioned in this
announcement will be made solely to "qualified institutional buyers" as
defined in Rule 144A under the Securities Act.

In any EEA Member State, this communication is only addressed to and is only
directed at qualified investors in that Member State within the meaning of the
Prospectus Regulation, i.e., only to investors who can receive the offer
without an approved prospectus in such EEA Member State. The expression
"Prospectus Regulation" means Regulation (EU) 2017/1129 as amended (together
with any applicable implementing measures in any Member State).

This communication is only being distributed to and is only directed at
persons in the United Kingdom that are "qualified investors" as defined in
paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading
Regulations 2024, and who are (i) investment professionals falling within
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005, as amended (the "Order") or (ii) high net worth
entities, and other persons to whom this announcement may lawfully be
communicated, falling within Article 49(2)(a) to (d) of the Order (all such
persons together being referred to as "relevant persons"). This communication
must not be acted on or relied on by persons who are not relevant persons. Any
investment or investment activity to which this communication relates is
available only for relevant persons and will be engaged in only with relevant
persons. Persons distributing this communication must satisfy themselves that
it is lawful to do so.

Matters discussed in this announcement may constitute forward-looking
statements. Forward-looking statements are statements that are not historical
facts and may be identified by words such as "believe", "expect",
"anticipate", "strategy", "intends", "estimate", "will", "may", "continue",
"should" and similar expressions. The forward-looking statements in this
release are based upon various assumptions, many of which are based, in turn,
upon further assumptions. Although the Company believes that these assumptions
were reasonable when made, these assumptions are inherently subject to
significant known and unknown risks, uncertainties, contingencies and other
important factors which are difficult or impossible to predict, and are beyond
its control. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this release by such forward-looking statements. The
Company does not make any guarantee that the assumptions underlying the
forward-looking statements in this announcement are free from errors nor does
it accept any responsibility for the future accuracy of the opinions expressed
in this announcement or any obligation to update or revise the statements in
this announcement to reflect subsequent events. You should not place undue
reliance on the forward-looking statements in this announcement. The
information, opinions and forward-looking statements contained in this
announcement speak only as at its date, and are subject to change without
notice. The Company does not undertake any obligation to review, update,
confirm, or to release publicly any revisions to any forward-looking
statements to reflect events that occur or circumstances that arise in
relation to the content of this announcement.

Neither the Manager nor any of its affiliates makes any representation as to
the accuracy or completeness of this announcement and none of them accepts any
responsibility for the contents of this announcement or any matters referred
to herein.

This announcement is for information purposes only and is not to be relied
upon in substitution for the exercise of independent judgment. It is not
intended as investment advice and under no circumstances is it to be used or
considered as an offer to sell, or a solicitation of an offer to buy any
securities or a recommendation to buy or sell any securities of the Company.
Neither the Manager nor any of its affiliates accept any liability arising
from the use of this announcement.

The distribution of this announcement and other information may be restricted
by law in certain jurisdictions. Persons into whose possession this
announcement or such other information should come are required to inform
themselves about and to observe any such restrictions


667687_Elliptic Labs- Private placement successfully placed.pdf

Source

Elliptic Laboratories ASA

Provider

Oslo Børs Newspoint

Company Name

ELLIPTIC LABORATORIES ASA

ISIN

NO0010722283

Symbol

ELABS

Market

Euronext Oslo Børs